ENTITY

Eikon Therapeutics (EIKN US)

14
Analysis
Health Care • United States
more
Exchange Announcement • 13 Aug 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 04 Aug 2026 04:39

Current Report (Form 8-K | Period ending 2026-07-31)

Exchange Announcement • 11 Jun 2026 04:15

Current Report (Form 8-K | Period ending 2026-06-05)

Exchange Announcement • 01 Jun 2026 19:30

Current Report (Form 8-K | Period ending 2026-05-30)

Exchange Announcement • 12 May 2026 04:13

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

x